뼈 성장 자극기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global Bone Growth Stimulator Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers detailed insights into the market landscape, assisting stakeholders in making informed strategic decisions.

Key Insights:

• Bone Growth Stimulator Market Size (2024E): US$2.26 Bn
• Projected Market Value (2031F): US$3.31 Bn
• Global Market Growth Rate (CAGR 2024 to 2031): 5.6%

Bone Growth Stimulator Market - Report Scope:

Bone growth stimulators are medical devices used to enhance the natural healing process of bones, particularly in cases of fractures, spinal fusions, or bone-related surgeries. These devices work by delivering electrical or ultrasonic waves to stimulate bone regeneration and healing. The market for bone growth stimulators is driven by the increasing prevalence of bone-related conditions such as osteoporosis and fractures, coupled with a growing demand for non-invasive treatment methods. The market also benefits from advancements in medical technology and a rise in the elderly population prone to bone injuries.

Market Growth Drivers:

Key factors propelling the growth of the global Bone Growth Stimulator market include the rising number of bone fractures and spinal surgeries, growing geriatric populations, and the increasing prevalence of orthopedic diseases. The demand for faster, more effective healing methods, particularly in spinal fusion surgeries, is boosting market adoption. Additionally, the growing awareness of non-invasive treatment options and the advancements in bone growth stimulation technologies, such as implantable and portable devices, are fueling market growth. Government support for healthcare infrastructure and increasing healthcare expenditure are also contributing to the market's expansion.

Market Restraints:

Despite the growth potential, the Bone Growth Stimulator market faces challenges such as the high cost of these devices, which limits their adoption, particularly in emerging economies. Reimbursement issues and a lack of widespread awareness regarding the benefits of bone growth stimulators also hinder market growth. Additionally, some patients may experience reluctance toward implantable devices or non-invasive treatments, further restraining market adoption. The stringent regulatory approval process for medical devices can also be a barrier for manufacturers.

Market Opportunities:

The Bone Growth Stimulator market presents substantial growth opportunities, particularly in the development of portable, cost-effective, and advanced bone healing devices. There is a growing opportunity for manufacturers to expand their presence in emerging markets, where healthcare infrastructure is rapidly improving. Technological innovations, including the integration of digital monitoring tools and minimally invasive solutions, are creating new avenues for market growth. Collaborations between medical device companies, research institutions, and healthcare providers will help advance product development and drive market penetration.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global Bone Growth Stimulator market?
• Which regions and market segments are experiencing the highest demand for bone growth stimulators?
• How are technological advancements in bone stimulation influencing market competition?
• Who are the major players in the Bone Growth Stimulator market, and what strategies are they adopting to stay competitive?
• What are the emerging trends and future growth prospects in the global Bone Growth Stimulator market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Bone Growth Stimulator market, such as Zimmer Biomet Holdings, Inc., Medtronic plc, and Orthofix Medical Inc., are focusing on innovation, product development, and strategic collaborations to maintain their market leadership. These companies are investing heavily in research and development to create next-generation bone growth stimulators that are more efficient and user-friendly. Expanding distribution networks and forming partnerships with hospitals and orthopedic centers are critical for market penetration. Additionally, ensuring regulatory compliance and patient education on the benefits of bone growth stimulators are key strategies for sustaining market growth.

Key Companies Profiled:

• Orthofix Holdings, Inc.
• Medtronic
• Zimmer Biomet
• DePuy Synthes
• Arthrex, Inc.
• Bioventus
• DJO Global, Inc.
• Ossatec benelux
• BTT Health GmbH
• IGEA
• Isto Biologics

Bone Growth Stimulator Industry Research by Category:

By Product

• Bone growth stimulation devices
• Bone Morphogenetic Proteins (BMP)
• Platelet-Rich Plasma (PRP)

By Application

• Spinal fusion surgeries
• Delayed union & nonunion bone fractures
• Orthopedic trauma surgeries
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Bone Growth Stimulator Market Snapshot, 2024-2031
• 1.2. Market Opportunity Assessment, 2024-2031, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global GDP Growth Outlook
  • 2.3.2. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Disease Epidemiology
• 3.3. Regulatory Landscape
• 3.4. Value Chain Analysis
• 3.5. Key Deals and Mergers
• 3.6. PESTLE Analysis
• 3.7. Porter's Five Force Analysis

4. Global Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 4.1. Global Bone Growth Stimulator Market Outlook: Product
  • 4.1.1. Introduction / Key Findings
  • 4.1.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
  • 4.1.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
    • 4.1.3.1. Bone growth stimulation devices
    • 4.1.3.2. Bone Morphogenetic Proteins (BMP)
    • 4.1.3.3. Platelet-Rich Plasma (PRP)
• 4.2. Market Attractiveness Analysis: Product
• 4.3. Global Bone Growth Stimulator Market Outlook: Application
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2023
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
    • 4.3.3.1. Spinal fusion surgeries
    • 4.3.3.2. Delayed union & nonunion bone fractures
    • 4.3.3.3. Orthopedic trauma surgeries
    • 4.3.3.4. Others
• 4.4. Market Attractiveness Analysis: Application

5. Global Bone Growth Stimulator Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2031
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 6.3.1. By Country
  • 6.3.2. By Product
  • 6.3.3. By Application
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 6.4.1. U.S.
  • 6.4.2. Canada
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  • 6.5.1. Bone growth stimulation devices
  • 6.5.2. Bone Morphogenetic Proteins (BMP)
  • 6.5.3. Platelet-Rich Plasma (PRP)
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 6.6.1. Spinal fusion surgeries
  • 6.6.2. Delayed union & nonunion bone fractures
  • 6.6.3. Orthopedic trauma surgeries
  • 6.6.4. Others
• 6.7. Market Attractiveness Analysis

7. Europe Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 7.3.1. By Country
  • 7.3.2. By Product
  • 7.3.3. By Application
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 7.4.1. Germany
  • 7.4.2. France
  • 7.4.3. U.K.
  • 7.4.4. Italy
  • 7.4.5. Spain
  • 7.4.6. Russia
  • 7.4.7. Turkiye
  • 7.4.8. Rest of Europe
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  • 7.5.1. Bone growth stimulation devices
  • 7.5.2. Bone Morphogenetic Proteins (BMP)
  • 7.5.3. Platelet-Rich Plasma (PRP)
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 7.6.1. Spinal fusion surgeries
  • 7.6.2. Delayed union & nonunion bone fractures
  • 7.6.3. Orthopedic trauma surgeries
  • 7.6.4. Others
• 7.7. Market Attractiveness Analysis

8. East Asia Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 8.3.1. By Country
  • 8.3.2. By Product
  • 8.3.3. By Application
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 8.4.1. China
  • 8.4.2. Japan
  • 8.4.3. South Korea
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  • 8.5.1. Bone growth stimulation devices
  • 8.5.2. Bone Morphogenetic Proteins (BMP)
  • 8.5.3. Platelet-Rich Plasma (PRP)
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 8.6.1. Spinal fusion surgeries
  • 8.6.2. Delayed union & nonunion bone fractures
  • 8.6.3. Orthopedic trauma surgeries
  • 8.6.4. Others
• 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 9.3.1. By Country
  • 9.3.2. By Product
  • 9.3.3. By Application
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 9.4.1. India
  • 9.4.2. Southeast Asia
  • 9.4.3. ANZ
  • 9.4.4. Rest of South Asia & Oceania
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  • 9.5.1. Bone growth stimulation devices
  • 9.5.2. Bone Morphogenetic Proteins (BMP)
  • 9.5.3. Platelet-Rich Plasma (PRP)
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 9.6.1. Spinal fusion surgeries
  • 9.6.2. Delayed union & nonunion bone fractures
  • 9.6.3. Orthopedic trauma surgeries
  • 9.6.4. Others
• 9.7. Market Attractiveness Analysis

10. Latin America Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 10.3.1. By Country
  • 10.3.2. By Product
  • 10.3.3. By Application
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 10.4.1. Brazil
  • 10.4.2. Mexico
  • 10.4.3. Rest of Latin America
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  • 10.5.1. Bone growth stimulation devices
  • 10.5.2. Bone Morphogenetic Proteins (BMP)
  • 10.5.3. Platelet-Rich Plasma (PRP)
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 10.6.1. Spinal fusion surgeries
  • 10.6.2. Delayed union & nonunion bone fractures
  • 10.6.3. Orthopedic trauma surgeries
  • 10.6.4. Others
• 10.7. Market Attractiveness Analysis

11. Middle East & Africa Bone Growth Stimulator Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

• 11.1. Key Highlights
• 11.2. Pricing Analysis
• 11.3. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 11.3.1. By Country
  • 11.3.2. By Product
  • 11.3.3. By Application
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2031
  • 11.4.1. GCC Countries
  • 11.4.2. Egypt
  • 11.4.3. South Africa
  • 11.4.4. Northern Africa
  • 11.4.5. Rest of Middle East & Africa
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2031
  • 11.5.1. Bone growth stimulation devices
  • 11.5.2. Bone Morphogenetic Proteins (BMP)
  • 11.5.3. Platelet-Rich Plasma (PRP)
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2024-2031
  • 11.6.1. Spinal fusion surgeries
  • 11.6.2. Delayed union & nonunion bone fractures
  • 11.6.3. Orthopedic trauma surgeries
  • 11.6.4. Others
• 11.7. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2024
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. Orthofix Holdings, Inc.
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. Medtronic
  • 12.3.3. Zimmer Biomet
  • 12.3.4. DePuy Synthes
  • 12.3.5. Arthrex, Inc.
  • 12.3.6. Bioventus
  • 12.3.7. DJO Global, Inc.
  • 12.3.8. Ossatec benelux
  • 12.3.9. BTT Health GmbH
  • 12.3.10. IGEA
  • 12.3.11. Isto Biologics
  • 12.3.12. Others

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations